SNV-001
- Generic Name
- SNV-001
A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781
- First Posted Date
- 2017-04-27
- Last Posted Date
- 2018-04-03
- Lead Sponsor
- Nabriva Therapeutics AG
- Target Recruit Count
- 10
- Registration Number
- NCT03131141
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, United Kingdom
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Nabriva Therapeutics AG
- Target Recruit Count
- 210
- Registration Number
- NCT01119105
- Locations
- 🇺🇸
BC-3781 Study Center 002, Chula Vista, California, United States
🇺🇸BC-3781 Study Center 003, Oceanside, California, United States
🇺🇸BC-3781 Study Center 012, Columbus, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath